ArticleTzu chi medical journal

Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease.

Chi-Chong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.